U.S. pharma huge copyright scrapped two experimental weight loss pills previous yr—a when-daily tablet, lotiglipron, as a result of elevated liver enzymes as well as a twice-everyday pill, danuglipron, as a result of powerful Unwanted effects—but CEO Albert Bourla has claimed the company is set to “Enjoy and acquire” while in the being over